Cargando…
非小细胞肺癌EGFR外显子20插入突变检测和靶向药物研究进展
Epidermal growth factor receptor exon 20 insertion (EGFR ex20ins) is one of the earliest driver gene activation mutations in non-small cell lung cancer (NSCLC). However, due to the unique structure of protein variation caused by this mutation, most patients with EGFR ex20ins mutation (except A763_Y7...
Autores principales: | WANG, Yulu, CHU, Tianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033239/ https://www.ncbi.nlm.nih.gov/pubmed/36872052 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.06 |
Ejemplares similares
-
EGFR外显子20插入突变型NSCLC治疗的研究进展
por: XU, Meiyi, et al.
Publicado: (2023) -
MET 14外显子跳跃突变NSCLC靶向治疗专家共识
Publicado: (2023) -
EGFR外显子20插入突变阳性NSCLC治疗的临床研究进展
Publicado: (2022) -
EGFR基因20外显子插入突变在非小细胞肺癌的研究及其进展
Publicado: (2020) -
EGFR 20外显子插入突变非小细胞肺癌规范化诊疗中国专家共识(2023版)
Publicado: (2023)